Fear of disease progression in patients with breast cancer in stages 1, 2 and 3. Malignant neoplasm of nipple and areola, right female breast
Conditions
Interventions
Intervention 1: Intervention group: 5 sessions of 90-minute group therapy based on acceptance and commitment, which was first proposed by Dr. Hayes. (Dr. Zenozian and Dr. Patterson, with the help of t
Sponsors
Zanjan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: Age range 18 to 50 years No tumor metastasis Patients who have only had 1 to 3 sessions of chemotherapy or radiotherapy Patients must either be from Zanjan or have been staying in a guest house for at least 2 months To have Physically ability to attend sessions No psychosis disorders and personality disorders Haven't been in psychotherapy during the last month Not using psychiatric drugs No diagnosis of misue of alcohol or addictive substances Patients' satisfaction and interest in participating in the study
Exclusion criteria
Exclusion criteria: Patients' dissatisfaction with continuing treatment Worsening of patients' mental or physical condition during treatment Absence of more than one session of treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Score of fear of disease progression questionnaire. Timepoint: Filling in the fear questionnaire of disease progression before the intervention, after the intervention and 3 months after the intervention. Method of measurement: Dr. Hersbach's Fear of Progress Questionnaire.;Quality of life questionnaire score for cancer patients. Timepoint: Filling out the quality of life questionnaire for cancer patients before the intervention, after the intervention, 3 months after the intervention. Method of measurement: Quality of life questionnaire for cancer patients.;Anxiety sensitivity questionnaire score. Timepoint: Filling out the anxiety sensitivity questionnaire before the intervention, after the intervention, 3 months after the intervention. Method of measurement: Anxiety Sensitivity Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Scale of experimental avoidance subscale of Acceptance and Practice Questionnaire. Timepoint: Admission and practice questionnaire is completed before the intervention, after the intervention, 3 months after the intervention. Method of measurement: Bond's Admission and practice questionnaire.;Psychological flexibility (acceptance and practice questionnaire score). Timepoint: Admission and practice questionnaire is filled out before the intervention, after the intervention and 3 months after the intervention. Method of measurement: Bond's Acceptance and practice questionnaire.;Cognitive integration (Gilders Cognitive integration questionnaire score). Timepoint: The cognitive integration questionnaire is filled out before the intervention, after the intervention and 3 months after the intervention. Method of measurement: Gilders Cognitive Integration Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Hassani alimolk
Zanjan University of Medical Sciences
Outcome results
None listed